News & Current Affairs |
Society for Brain Mapping and therapeutics

G20 World Brain Mapping Initiative/Summit in Australia include Messages of Collaboration from Congressman Chaka Fattah, Congressman Earl Blumenauer and Member of the Canadian Parliament, Kirsty Duncan and pioneering work by the tope G20 scientists

G20 World Brain Mapping Initiative/Summit in Australia include Messages of Collaboration from Congressman Chaka Fattah, Congressman Earl Blumenauer and Member of the Canadian Parliament, Kirsty Duncan and pioneering work by the tope G20 scientists


Brisbane, Australia- The Society for Brain Mapping & Therapeutics (SBMT), the Amen Clinics and Compumedics Inc, is holding its first annual summit on G20 World Brain Mapping and Therapeutics Initiative in Brisbane, Australia on Nov. 13th in Mercure Hotel.  The initiative is aimed at bringing the finest scientists, engineers, physicians and surgeons across the globe in order to rapidly introduce clinical solutions for neurological disorders, which cost the world economy hundreds of billions of dollars annually.  

“I am proud that I could play a significant role in helping Australia host the first annual G20 World Brain Mapping and Therapeutics this year. On behalf of Australian colleagues, I welcome our colleagues across the world in this unique think-tank summit, which is truly aimed at advancing the field of brain mapping and therapeutics” said Dr. Kuldip Sidhu, Professor of Stem Cell at UNSW, the Past President of SBMT and a current President of SBMT-Australia. 

According to the World Health Organization's large-scale studies, about a third of the adult worldwide population suffer from a mental disorder such as depression, anxiety and schizophrenia. If also taken together with neurological disorders, such as dementia and stroke, these "disorders of the brain" account for 13% of the global disease burden. This surpasses both cardiovascular diseases (5%) and cancer (10%). Countries with the highest rate of neurological disorders included the USA, UK, Russia, and Australia.

“The time and place of the G20 meeting in Australia this year is the perfect back drop for a scientific summit on how we can work together and introduce novel diagnostics and therapeutics in the field, which could reduce the cost of the healthcare and increase the efficiency of healthcare delivery” said, Dr. Pantaleo Romanelli, President Elect of SBMT; Consultant and Scientific Director, Brain Radiosurgery, Cyberknife Center, Milano, Italy; Visiting Scientist, European Synchrotron Radiation Facility(ESRF), Grenoble, France; President of SBMT Europe.

The summit will start with messages of cooperation from the U.S. Congressman Fattah, the U.S. Congressman Blumenauer (Chairman of the Congressional Neuroscience Caucus) and Member of the Canadian Parliament, Kirsty Duncan.  These leaders encourage all scientists to work together in order to curb the growing cost associated with diagnosis and treatment of neurological disorders through introducing game-changing diagnostics and therapeutics. 

“South Africa is the gateway to the African Continent. Initiatives like this could help us bring the best science and technology to our patients and help us to train the best scientists and physicians by engaging with pioneers in the filed through SBMT. We are delighted to be a part of this initiative and completely support this effort,” said Dr. John Ouma, Secretary General of South Africa Neurosurgical Society; Director of Department of Neurosurgery, University of the Witwatersrand, Johannesburg, South Africa.

The summit program includes talks from top US, Australian, Italian, Turkish, and European Brain Mapping Initiative scientists covering topics such as advanced imaging in diagnosis of Alzheimer’s disease, psychiatric disorders, brain cancers, neurodegenerative disorders, big data in brain mapping, strategies for global clinical trials, policies that could facilitate translation, integration and commercialization of devices and therapeutics such as nanoneurosurgery/nanoneuroscience, neurotrauma, and military medicine, as well as a roundtable discussion with the US and Canadian Policymakers

“This initiative is designed to break boundaries of science, technology, medicine, art, and healthcare policy, which could truly help to facilitate rapid introduction of advanced diagnostics and therapeutics.  Such advancements could increase efficiency of the healthcare delivery, improve clinical outcome and reduce the cost of the healthcare worldwide,” said, Dr. Babak Kateb, Chairman of the Board of the SBMT, President of Brain Mapping Foundation, Director of National Center of NanoBioElectroncs and Research Scientist, Department of Neurosurgery, Cedars-Sinai Medical Center.

The Summit aims to contribute to the existing global initiatives such as President Obama’s BRAIN Initiative and European Human Brain Project.  The G20 ministers, ambassadors, science and trade attachés are invited to this unique event.

“We are delighted to welcome you to the 2016 G20 World Brain Mapping and Therapeutic Initiative-Summit in Turkey and fully support the SBMT-G20 initiative” said Dr. Y. Sukru Caglar, Professor of Neurosurgery at University Ankara, and Secretary General of Turkish Neurosurgical Association.


Media Contact:

Dr. Babak Kateb

Tel: 310-9808340

About SBMT: